Original research
Evaluation of recombinant invasive, non-pathogenic Eschericia coli as a vaccine vector against the intracellular pathogen, Brucella
-
* Corresponding author: Jerome S Harms harms@svm.vetmed.wisc.edu
Journal of Immune Based Therapies and Vaccines 2009, 7:1 doi:10.1186/1476-8518-7-1
No comments have yet been made on this article.